31
May
Good to see responsible interpretation of the data
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data NEWARK, Calif., May 31, 2016 (GLOBE NEWSWIRE) — StemCells, Inc. (NASDAQ: STEM) (the “Company”) today announced its decision to terminate the Company’s Phase II Pathway Study in…
Read More